Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSERT: SABR vs EBRT for Prostate Cancer
NCT02594072Unknown
- Sponsor
- University of British Columbia
- Start
- Apr 2016
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of British Columbia. Primary endpoint: Number of subjects experiencing treatment-related acute and late toxicities at 5 years. Status: unknown.
Beyond the preview
Go deeper on NCT02594072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594072.